Corrigendum to "In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphorohydrazine derivatives of coumarin and chromone" [Eur J Med Chem 41 (11) (2006) 1301-1309] (DOI:10.1016/j.ejmech.2006.06.004);In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphorohydrazine derivatives of coumarin and chromone

European Journal of Medicinal Chemistry

Volumn 41, Issue 11, 2006, Pages 1301-1309

  Nawrot Modranka, Jolanta ^a   Nawrot, Ewa ^a   Graczyk, Julita ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Alkylating properties; Antibacterial activity; Antitumor activity; Chromone; Coumarin; Phosphorohydrazine; Tautomerism

Indexed keywords

3 [[(DIETHOXYTHIOPHOSPHONYL) HYDRAZONO] METHYLEN] 4 HYDROXY 2H 1 BENZOPYRAN 2 ONE; 3 [[(DIETHOXYTHIOPHOSPHORYL) HYDRAZINO] METHYLIDENE] 3,4 DIHYDRO 2H 1 BENZOPYRAN 2,4 DIONE; 3 [[(DIETHOXYTHIOPHOSPHORYL) HYDRAZONO] METHYLEN] 4H 1 BENZOPYRAN 4 ONE; 3 [[(DIETHOXYTHIOPHOSPHORYL) METHYLHYDRAZONO]METHYLEN] 4 HYDROXY 2H 1 BENZOPYRAN 2 ONE; 3 [[(DIETHOXYTHIOPHOSPHORYL) METYLHYDRAZINO] METHYLIDENE] 3,4 DIHYDRO 2H 1 BENZOPYRAN 2,4 DIONE; 3 [[(DIETOXYTHIOPHOSPHORYL) METHYLHYDRAZINO]CARBONYL] 4H 1 BENZOPYRAN 4 ONE; 3 [[(DIMETHOXYTHIOPHOSPHORYL) METHYLHYDRAZINO] METHYLEN] 4 HYDROXY 2H 1BENZOPYRAN 2 ONE; 3 [[(DIMETHOXYTHIOPHOSPHORYL) METHYLHYDRAZINO]CARBONYL] 4H 1 BENZOPYRAN 4 ONE; 3 [[(DIMETHOXYTHIOPHOSPHORYL) METHYLHYDRAZONO] METHYLEN] 4H 1 BENZOPYRAN 4 ONE; 3 [[DIMETHOXYTHIOPHOSPHORYL) METHYLHYDRAZINO] METHYLIDENE] 3,4 DIHYDRO 2H 1 BENZOPYRAN 2,4 DIONE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; HYDRAZIDE DERIVATIVE; METHOTREXATE; PHOSPHORUS HYDRAZIDE; UNCLASSIFIED DRUG; ALKYLATING AGENT; CHROMONE DERIVATIVE; COUMARIN DERIVATIVE; HYDRAZONE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBACTERIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG TRANSFORMATION; IN VITRO STUDY; IN VIVO STUDY; ISOMERISM; LEUKEMIA; LEUKEMIA CELL; MALE; MOUSE; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; STRUCTURE ACTIVITY RELATION; ANIMAL; BAGG ALBINO MOUSE; CHEMISTRY; DBA MOUSE; DRUG EFFECT; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; LEUKEMIA L 1210; LEUKEMIA P 388; MICROBIOLOGICAL EXAMINATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS, ALKYLATING; CHROMONES; COUMARINS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HYDRAZONES; LEUKEMIA L1210; LEUKEMIA P388; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED DBA; MICROBIAL SENSITIVITY TESTS;

EID: 33750594445     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.03.001     Document Type: Erratum

References (51)

1. Gabor M. (1988), The Pharmacology of Benzopyrone Derivatives and Related Compounds, Akademiai Kiado, Budapest 91-126 (pp. 179-233)
2. Kawase M., Varu B., Shah A., Motohashi N., Tani S., Saito S., Debnath S., Mahapatra S., Dastidar S.G., and Chakrabarty A.N. Arzneim.-Forsch/Drug Res. 51 (2001) 67-71
3. O. Kayser, H. Kolodziej, Z. Naturforsch, 54 (1999) 169-174.
4. Jimenez-Orozco F.A., Lopez-Gonzalez J.S., Nieto-Rodriquez A., Velasco-Velazquez M.A., Molina-Guarneros J.A., Mendoza-Patino N., Garcia-Mondragon M.J., Elizalde-Galvan P., Leon-Cedeno F., and Mandoki J.J. Lung Cancer 34 (2001) 185-194
5. Valenti P., Fabbri G., Rampa A., Bisi A., Gobbi S., Da Re P., Carrara M., Sgevano A., and Cima L. Anticancer Drug Des. 11 (1996) 243-252
6. Kirkiacharian S., Thuy D.T., Sicsic S., Bakhchinian R., Kurkjian R., and Tonnaire T. Farmaco 57 (2002) 703-708
7. Mao P.C.-M., Mouscadet J.F., Leh H., Auclair C., and Hsu L.Y. Chem. Pharm. Bull. (Tokyo) 50 (2002) 1634-1637
8. Zyner E., and Ochocki J. Acta Poloniae Pharmaceutica-Drug Res. 56 (1999) 159-167
9. Budzisz E., Graczyk-Wojciechowska J., Zie{ogonek}ba R., Nawrot B., and New J. Chem. 26 (2002) 1799-1804
10. Budzisz E., Brzezińska E., Krajewska U., and Różalski M. Eur. J. Med. Chem. 38 (2003) 597-603
11. Katti K.V., Reddy V.S., and Singh P.R. (1999), Chemical Society Reviews 97-107
12. Wang M., Volkert E.W., Singh P.R., Katti K.K., Lusiak P., Katti K.V., and Barnes C.L. Inorg. Chem. 33 (1994) 1184-1187
13. Katti K.V., Singh P.R., and Barnes C.L. J. Chem. Soc., Dalton Trans. 21 (1993) 53-2156
14. Katti K.V., Singh P.R., and Barnes C.L. Inorg. Chem. 31 (1992) 4588-4593
15. Nawrot-Modranka J., Ochocki J., and Graczyk J. Pharmazie 59 (2004) 731-732
16. Nawrot-Modranka J., and Kostka K. Pol. J. Chem. 69 (1995) 1148-1152
17. Nawrot-Modranka J. Pol. J. Chem. 69 (1995) 1250-1256
18. Rybarczyk-Pirek A.J., Olszak T.A., Małecka M., and Nawrot-Modranka J. Acta Cryst. Sect. C 55 (1999) 1313-1315
19. Rybarczyk-Pirek A.J., Grabowski S.J., Małecka M., and Nawrot-Modranka J. J. Phys. Chem. A 106 (2002) 11956-11962
20. Rybarczyk-Pirek A.J., Małecka M., Grabowski S.J., and Nawrot-Modranka J. Acta Cryst. Sect. C 58 (2002) 405-406
21. Rybarczyk-Pirek A.J., Grabowski S.J., and Nawrot-Modranka J. J. Phys. Chem. A 107 (2003) 9232-9239
22. Rybarczyk-Pirek A.J., and Nawrot-Modranka J. Acta Cryst. Sect. E 60 (2004) 988-990
23. Rybarczyk-Pirek A.J., Dubis A.T., Grabowski S.J., and Nawrot-Modranka J. Chem. Phys. 320 (2006) 247-258
24. Ochocki J., and Zyner E. (2003), PL Patent nr. P185585
25. Zyner E., Graczyk J., and Ochocki J. Pharmazie 54 (1999) 945-946
26. Kośmider B., Wyszyńska K., Janik-Spiechowicz E., Osiecka R., Zyner E., Ochocki J., Ciesielska E., and Wasowicz W. Mutat. Res. 558 (2004) 93-110
27. Kośmider B., Zyner E., Osiecka R., and Ochocki J. Can. J. Phys. Pharm. 82 5 (2004) 353-358
28. Kośmider B., Osiecka R., Ciesielska E., Szmigiero L., Zyner E., and Ochocki J. Mutat. Res. 558 (2004) 169-179
29. Kośmider B., Zyner E., Osiecka R., and Ochocki J. Mutat. Res. 563 (2004) 61-67
30. Ghosh C.K., and Mukhopadhyay K.K. Synthesis (Mass.) (1978) 779-781
31. Chantegrel B., Nadi A.-J., and Gelin S. Tetrahedron Lett. 24 (1983) 381-384
32. Klutchko S., Shavel Jr. J., and Von Stradtmann M. J. Org. Chem. 39 (1974) 2436-2437
33. Babin P., Dunogues J., and Petraud M. Tetrahedron 37 (1981) 1131-1139
34. Arndt F., Loewe L., Ün R., and Ayca E. Chem. Ber. 84 (1951) 319-329
35. Szabo V., Borda J., and Theisz E. Acta Chim. Acad. Sci. Hung. 103 (1980) 271-279
36. Chantegrel B., Nadi A.J., and Gelin S. J. Org. Chem. 49 (1984) 4419-4424
37. Sigg I., Haas G., and Winkler T. Helv. Chim. Acta 65 (1982) 275-279
38. Fitton A.O., Frost J.R., Houghton P.G., Suschitzky H., and Chem J. Soc. Perkin I (1979) 1691-1694
39. Preussmann R., Schneider H., and Epple F. Arzneim-Forsch 19 (1969) 1059-1073
40. Shyam K., Penketh P.G., Divo A.A., Loomis R.H., Rose W.C., and Sartorelli A.C. J. Med. Chem. 36 (1993) 3496
41. Najman-Bronżewska L., and Ochocki J. Pharmazie 52 (1997) 198-202
42. Geran R.J., Greeberg N.H., Mac Donald M.M., Schumacher A.M., and Abbott B.J. Cancer Chemother. 3 (1972) 1-103
43. NCCLS, Villanowa, Pa. Methods for Dilution Antimicrobial Susceptibility Test for Bacteria That Grow Aerobically, fourth ed., Approved Standard. NCCLS document M7-A4, 1997.
44. Jerzmanowska Z., Basiński W., Zielińska R., and Polish J. Chem. 54 (1980) 383
45. Ghosh C.K., and Khan S. Synthesis (Mass.) 9 (1981) 719-721
46. Ghosh C.K., Bandyopadhyay C., and Tewari N. J. Org. Chem. 49 (1984) 2812-2815
47. Tolkmith H. J. Am. Chem. Soc. 84 (1962) 2097-2104
48. Cremins P.J., Saengchantara S.T., and Wallace T.W. Tetrahedron 43 (1987) 3075-3082
49. Nohara A., and Umetani T. Y. Sanno, Tetrahedron 30 (1974) 3553-3561
50. Klutchko S., Cohen M.P., Shavel Jr. J., and Von Strandtmann M. J. Heterocycl. Chem. 11 (1974) 183-188
51. Deichmann W.B., and Le Blance T.J. J. Industr. Hyg. Toxical. 25 (1943) 415-417